D. MEDICAL INDUSTRIES LTD.

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

No description available

Notice of Effectiveness

Notice of Effectiveness

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Post-effective amendment to a registration statement

Post Effective Amendment to S-8

Post-effective amendment to a registration statement

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G) (amendment)

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

Notification of removal from listing and/or registration on a national securities exchange

Registration statement / Annual report / Transition report for Foreign Private Issuers

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G) (amendment)

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G) (amendment)

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G) (amendment)

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G) (amendment)

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G) (amendment)

Notice of Effectiveness

Correspondence with the SEC

Registration statement for securities of certain foreign private issuers (amendment)

Letter from the SEC

Registration statement / Annual report / Transition report for Foreign Private Issuers (amendment)

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

Letter from the SEC

Registration statement for securities of certain foreign private issuers

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G)

Registration statement / Annual report / Transition report for Foreign Private Issuers

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G)

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G) (amendment)

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G)

Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans

No description available

Beneficial ownership report for a passive holder of more than 5% (Schedule 13G)

No description available

Prospectus Supplement with Pricing Information

Registration statement for securities of certain foreign private issuers (amendment)

Notice of Effectiveness

Registration statement for securities of certain foreign private issuers (amendment)

No description available

Registration statement for securities of certain foreign private issuers (amendment)

Free Writing Prospectus

Registration of Securities on Exchange

Registration statement for securities of certain foreign private issuers (amendment)

Registration statement for securities of certain foreign private issuers (amendment)

Registration statement for securities of certain foreign private issuers (amendment)